The effects of telemedicine intervention on weight loss in obese sleep apnea patients with CPAP use
- Conditions
- Obesity Obstructive Sleep Apnea
- Registration Number
- JPRN-UMIN000033607
- Lead Sponsor
- Respiratory Care and Sleep Contorol Medicine, Graduate School of Medicine, Kyoto University
- Brief Summary
The participants were invited from November 2018 to December 2019. The follow-up has been completed in August 2020. One hundred sixty-eight participants were evenly randomized to either of two groups. The percentage of participants who achieved the primary outcome was significantly higher in the Multimodal-telemonitoring (MM-TM) group than CPAP-telemonitoring (CPAP-TM) group (39.3% vs. 25.0%, p=0.047)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 168
Not provided
1.Secondary obesity (Obesity because of medication and endocrine disorder) 2.Impaired cognition 3.Chronic diseases affecting body weight (e.g. active malignancy and collagen diseases) 4.Dialysis 5.Body weight is more than or equal to 135kg (The Weight scale provided in this study cannot measure precisely for these patients.) 6.Attending physician recognize that exercise therapy cannot be recommended (BP >180/100, unstable angina, heart failure, respiratory failure, diabetes with renal failure, stroke and joint pain etc) 7. Hospitalization is scheduled during the study period 8. New nutritional or exercise therapy is scheduled during the study period for different purposes from that of the present study 9. The patient who has to see the attending physician every month or every two months for other reasons than CPAP management 10 Telemedicine intervention has already been started 11. Home oxygen therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method